Denis Lucquin joined Sofinnova Partners in 1991 and spent more than three decades at the firm, serving as its Chairman until 2017 and as a Managing Partner until 2021, after which the firm's site listed him as Managing Partner Emeritus. Before Sofinnova he headed the technology transfer department at INRA and in 1989 became director of investments at Innolion, the venture arm of Credit Lyonnais. He was the principal architect of Sofinnova's industrial biotechnology strategy and, according to BioCentury, invested in 31 biotech companies including Ablynx, Nicox and Novexel. He co-founded France Biotech in 1997 and died on 3 April 2026 at the age of 69.
Education
Engineering degree, Ecole Polytechnique
Ecole du Genie Rural des Eaux et Forets
Innovation Management, Universite de Paris-Dauphine
Previous Experience
Director of investments, Innolion (Credit Lyonnais)
Head of the technology transfer department, Institut National de la Recherche Agronomique (INRA)